Combined Oral Contraceptive Effects on Low-Grade Chronic Inflammatory Mediators in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Combined Oral Contraceptive Effects on Low-Grade Chronic Inflammatory Mediators in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Polycystic ovary syndrome is associated with dyslipidemia, dysglycemia, metabolic syndrome, and low-grade chronic inflammation, which increase the risks for cardiovascular disease. Combined oral contraceptives may affect the mediators of low-grade chronic inflammation with potential additive risk in...

Full description

Bibliographic Details
Main Authors:	Sebastião Freitas de Medeiros, Matheus Antônio Souto de Medeiros, Nayara de Souza Santos, Bruna Barcelo Barbosa, Márcia Marly Winck Yamamoto
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	International Journal of Inflammation
Online Access:	http://dx.doi.org/10.1155/2018/9591509

Similar Items

Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age
by: Sebastião Freitas de Medeiros, et al.
Published: (2020-02-01)

Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
by: Sebastião Freitas de Medeiros, et al.
Published: (2017-09-01)

Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
by: Sebastião Freitas de Medeiros
Published: (2017-12-01)

An Update on Contraception in Polycystic Ovary Syndrome
by: Seda Hanife Oguz, et al.
Published: (2021-04-01)

Participação dos androgênios adrenais na síndrome dos ovários policísticos Adrenal androgen participation in the polycystic ovary syndrome
by: Angelo Barrionuevo Gil Junior, et al.
Published: (2010-11-01)

Atividade das enzimas corticoesteroidogênicas em pacientes normoandrogênicas e hiperandrogênicas com síndrome dos ovários policísticos Activities of the corticosteroidogenic enzimes in normoandrogenic and hiperandrogenic patients with polycystic ovary syndrome
by: Márcia Marly Winck Yamamoto
Published: (2012-07-01)

Current insights into gonadotropic pituitary function in the polycystic ovary syndrome
by: Cristianne Serafim da Silva Feuser, et al.
Published: (2014-03-01)

COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME
by: M. A. Gevorkyan, et al.
Published: (2016-09-01)

Modificações dos níveis de gonadotrofinas durante a vida reprodutiva Gonadotropin level changes during the reproductive life
by: Sebastião Freitas de Medeiros, et al.
Published: (2007-01-01)

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
by: de Melo AS, et al.
Published: (2017-02-01)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
by: Yang YM, et al.
Published: (2015-09-01)

Polycystic ovary syndrome and circulating inflammatory markers
by: Farideh Zafari Zangeneh, et al.
Published: (2017-07-01)

Inflammatory Markers in Women with Polycystic Ovary Syndrome
by: E. Rudnicka, et al.
Published: (2020-01-01)

Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
by: Chan-Hong Park, et al.
Published: (2020-01-01)

Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception
by: T Iu Pestrikova, et al.
Published: (2016-08-01)

Cardiovascular and Inflammatory Risk Factors in Polycystic Ovary Syndrome
by: Blair, S. A.
Published: (2010)

Climacteric complaints among very low-income women from a tropical region of Brazil
by: Sebastião Freitas de Medeiros, et al.

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
by: Atanas Ignatov, et al.
Published: (2020-07-01)

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
by: Dorte Glintborg, et al.
Published: (2017-06-01)

Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome
by: Margareth Chiharu Iwata, et al.
Published: (2015-06-01)

Endocrine and metabolic changes in women with polycystic ovaries and polycystic ovary syndrome
by: Koivunen, R. (Riitta)
Published: (2001)

Clinical and endocrine features of Brazilian infertile women with or without endometriosis: A comparative cross-sectional study
by: Jacklyne Silva Barbosa, et al.
Published: (2014-12-01)

Polycystic Ovary Syndrome
Published: (2012)

Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
by: Ferdous Mehrabian, et al.
Published: (2016-01-01)

Polycystic ovary syndrome: implications of metabolic dysfunction
by: Márcio Augusto Pinto de Ávila, et al.

The Effect of Acupuncture on Decreasing Infertility Associated with Polycystic Ovary Syndrome
by: Ana Carolina Ramos de Freitas
Published: (2020)

The Pro-inflammatory IL6 and serum glucose in Polycystic Ovary Syndrome
by: Hayfaa S. AL-Hadithi, et al.
Published: (2013-07-01)

Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
by: Mina Amiri, et al.
Published: (2020-08-01)

Polycystic Ovary Syndrome Treatment
by: Patterson, Moneka Angilene
Published: (2017)

Polycystic Ovary Syndrome in Adolescence
by: Rebecca Deans
Published: (2019-10-01)

On the therapy for polycystic ovary syndrome
by: Vittorio Unfer, et al.
Published: (2017-01-01)

hyperandrogenism in polycystic ovary syndrome
by: malka S. Al- saadi
Published: (2006-01-01)

Kisspeptin and Polycystic Ovary Syndrome
by: Rong Tang, et al.
Published: (2019-05-01)

POLYCYSTIC OVARY SYNDROME IN ADOLESCENCE
by: Diana Baptista, et al.
Published: (2017-02-01)

Pregnancy in polycystic ovary syndrome
by: Sadishkumar Kamalanathan, et al.
Published: (2013-01-01)

The inositols and polycystic ovary syndrome
by: Bharti Kalra, et al.
Published: (2016-01-01)

Familial aspects of polycystic ovaries
by: Hague, W. M.
Published: (1988)

Association of vascular and inflammatory markers with metabolic disorders in women with polycystic ovary syndrome
by: Boshku Aleksandra Atanasova, et al.
Published: (2019-01-01)

The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta-analysis
by: Amie Woodward, et al.
Published: (2019-05-01)

Polycystic Ovary Syndrome Functional Investigation and Clinical Application
Published: (2022)

Cannot write session to /tmp/vufind_sessions/sess_373bfr1af0a1jieuva83e6fod0